Grants for County governments - Health

Partner Promotion of Strategies to Advance Oral Health Equity is a three-year competitive announcement that continues the Centers for Disease Control and Preventions (CDC) investment in supporting oral health programs. This Funding Opportunity Announcement aims to support recipients of CDC-RFA-DP-24-0048 (State Promotion of Strategies to Advance Oral Health Equity) to prevent and control oral diseases and related conditions among priority populations. Applicants may apply for Component 1, Component 2, or Component 3 separately or a combination of two or more. For all Components, the funded recipient(s) will work closely with staff from CDCs Division of Oral Health and all awardees of CDC-RFA-DP-24-0048. Under Component 1, the recipient will provide awardees with community water fluoridation; evidence-based preventive dental services; and oral health equity technical assistance, training, and subject matter expertise. Under Component 2, the recipient will provide awardees with technical assistance, training, and subject matter expertise related to oral health Infection Prevention and Control. Under Component 3, the recipient will provide awardees with oral health surveillance and evaluation technical assistance and assess efforts to reach priority populations. The proposed program will follow and build upon the Notice of Funding Opportunity for DP18-1811 [FY2018-FY2023].

Five Illinois counties, Alexander, Hardin, Pulaski, Gallatin and Saline; face a fundamental lack of mental health services for justice-involved youth; often having to take juveniles out of the home county for services. If the juveniles are in need of anything greater than outpatient treatment, these youth are sent outside of their home county and sent up to central Illinois, many miles away. Lack of social services coupled with the lack of public transportation, can make it very difficult for juveniles to access resources to avoid entering the Juvenile Justice system in the first place or to succeed while in the system.

This grant provides funding to organizations for developing a comprehensive outreach strategy to enhance awareness and participation in the Chesapeake Bay Program's restoration efforts across its watershed.

This funding opportunity supports educational programs that provide research experiences and mentoring to enhance the participation of diverse individuals in the scientific workforce related to hearing and communication disorders.

HRSA-25-002, HRSA-25-003, and HRSA-25-004 announces the opportunity to apply for funding under Ryan White HIV/AIDS Program (RWHAP) Part C Early Intervention Services (EIS) Program: Existing Geographic Service Areas. The purpose of this program is to provide comprehensive primary health care and support services in an outpatient setting for low-income people with HIV. Under this announcement, successful applicants must provide: (1) counseling for individuals with respect to HIV; (2) targeted HIV testing; (3) periodic medical evaluations of individuals with HIV and clinical and diagnostic services for HIV care and treatment; (4) therapeutic measures for preventing and treating the deterioration of the immune system, and for preventing and treating conditions arising from HIV; and (5) referrals for people with HIV to appropriate providers of health care and support services. These services are to be provided directly or through referrals, contracts, or memoranda of understanding (MOUs). This competition is open to current RWHAP Part C EIS recipients and new organizations proposing to provide RWHAP Part C EIS funded services in the geographic service areas listed in Appendix C. Please note that there are 3 funding announcement numbers included in this document with 3 different periods of performance (See Appendix C). If you are applying for more than one service area, you must submit a separate application for each proposed service area. All allowable services must relate to HIV diagnosis, care, and support, and must adhere to established HIV clinical practice standards consistent with U.S. Department of Health and Human Services (HHS) Guidelines. Please refer to the HIV/AIDS Bureau (HAB) Policy Clarification Notice (PCN) 16-02 Ryan White HIV/AIDS Program Services for a list of RWHAP allowable core medical and support services and their descriptions. According to the RWHAP Part C statute: At least 50 percent of the amount received under the award must be expended on EIS costs (except counseling and referrals/linkage to care); At least 75 percent of the award (after reserving amounts for administrative costs, planning/evaluation, and clinical quality management (CQM)) must be expended on core medical services costs (Please note: EIS is a subset of this 75 percent of the award) and; Not more than 10 percent of the total RWHAP Part C award funds can be expended on administrative costs. Applicants seeking a waiver to the core medical services requirement must submit a waiver request with this application as Attachment 15. For more details, see Program Requirements and Expectations.

The Blaine County Community Foundation Fund, established at the Montana Community Foundation (MCF) by Warren Ross in 1997, is offering grants to benefit communities and residents of Blaine County. The grant cycle runs from August 15 to November 15. The grants range in size from $500 to $2,000 and must be used for projects benefiting communities or residents in Blaine County. Eligible applicants must be either a 501(c)(3) nonprofit or an exempt governmental unit. The grantee organization does not need to be based in Blaine County. Only one application is allowed per organization. Eligible projects must provide a direct benefit to local residents, be sustainable, and address important, unmet needs. Ineligible projects include conferences, workshops, planning, research, untested projects, and partisan or sectarian activities. The grant requests are reviewed by the Blaine County Community Grantmaking Committee, and incomplete applications will not be considered. For additional help or inquiries, contact Taylor Crowl, Program Officer, Local Community Foundations, at 406-603-4913 or [email protected]. The application can be accessed at https://www.grantinterface.com/Home/Logon?urlkey=mtcommunity.

This grant provides financial support and resources to women entrepreneurs in Hawaii, particularly those from Native Hawaiian, Pacific Islander, or Asian backgrounds, to help grow their early-stage businesses.

This initiative provides funding to organizations that deliver culturally sensitive HIV prevention and care services to at-risk minority populations in Illinois, including men who have sex with men, homeless individuals, and those with histories of mental illness or substance abuse.

This funding opportunity supports the development of standardized data elements for Alzheimer’s Disease and related dementias research, inviting applications from universities, nonprofits, and other organizations to enhance data sharing and collaboration in the field.

This funding opportunity supports multidisciplinary research centers focused on understanding and improving the transmission of seasonal influenza viruses, inviting applications from a wide range of organizations, including universities, nonprofits, and government entities.

This funding opportunity provides financial support to various organizations working to strengthen public health systems in Kenya, focusing on preventing and responding to health threats and improving overall health security.

This funding opportunity provides additional financial support for early-stage cancer researchers who have made significant progress in their work, allowing them to extend their research efforts and move towards greater independence in their scientific careers.

This funding opportunity supports educational and mentorship programs that encourage undergraduate and post-baccalaureate students from diverse backgrounds to pursue careers in genomics research.

This funding opportunity announcement (FOA) invites research projects that seek to explain the underlying mechanisms, processes, and trajectories of social relationships and how these factors affect outcomes in human health, illness, recovery, and overall wellbeing. Types of projects submitted under this FOA include studies that prospectively assign human participants to conditions (i.e., experimentally manipulate independent variables) and that assess biomedical and/or behavioral outcomes in humans to understand fundamental aspects of phenomena related to social connectedness and isolatedness. NIH considers such studies as prospective basic science studies involving human participants that meet the NIH definition of basic research and fall within the NIH definition of clinical trials (see, e.g., NOT-OD-19-024) Types of studies that should submit under this FOA include studies that prospectively assign human participants to conditions (i.e., experimentally manipulate independent variables) and that assess biomedical or behavioral outcomes in humans for the purpose of understanding the fundamental aspects of phenomena without specific application towards processes or products in mind. Applications proposing studies that include but not limited to model animal research or observational studies involving humans should submit under the companion Clinical Trials Not Allowed version of this FOA.

The Project Grants initiative, offered by Working Assumptions, is a new program designed to support artists, writers, educators, social workers, therapists, and creatives in exploring the relationship between photography and family in expansive and inventive ways. Working Assumptions believes that photography can illuminate the complexities of family life and foster compassion, aligning with their mission to support projects that spur reflection and dialogue around family, care systems, and kinship. This program directly reflects the foundation's strategic priority to use photography as a medium for social commentary and understanding, operating under the theory of change that creative projects can significantly influence public perception and dialogue on critical societal structures like family. The primary beneficiaries of this grant are individual artists, collaborations, researchers, academics, journalists, educators, therapists, social workers, and creatives across disciplines who focus on photography and family. Applicants must have a prior track record of exploring family themes, be U.S. citizens or residents with a U.S. tax ID and bank account, and be at least 18 years old. The impact goals are to inspire audiences and participants to view family in new, meaningful ways through photography, fostering greater understanding and compassion for diverse family experiences. The program prioritizes projects that address underrepresented family arrangements, care work, memory, identity formation, and other related topics. While the grant offers unrestricted funding for creative freedom, it expects projects to be intended for public consumption, ranging from photography series and book projects to public art, mental health programs, long-form journalism, curriculum, performances, and digital or scholarly projects. This broad scope allows for diverse approaches to the central theme, ensuring a wide array of perspectives are brought to light. Expected outcomes include the creation and public dissemination of innovative photographic and interdisciplinary projects that provoke thought and dialogue. Measurable results will include the completion of 6 projects annually, each receiving $10,000 in funding over an 8-month grant period (September 15 to May 15). While the funding is unrestricted, the emphasis on public consumption implies that the success of these grants will also be measured by their reach and the degree to which they engage and inspire audiences to reflect on family dynamics and kinship.

This program provides emergency funding to local governments in Kansas for immediate health and welfare needs following recent disasters, excluding those already receiving CDBG entitlement funding.

This program provides funding to nonprofits, tribal organizations, disadvantaged farmers, and academic institutions to enhance the competitiveness of Nevada's specialty crops through marketing, research, and education initiatives.

This funding opportunity supports researchers investigating new and existing risk factors for liver cancer, focusing on population-based studies to improve understanding and prevention of the disease in the U.S.

This funding opportunity provides substantial financial support to state and local public health agencies to modernize their operations, expand their workforce, and improve data systems, ultimately enhancing public health services and addressing health disparities.

The purpose of this funding opportunity announcement (FOA) is to solicit applications for pilot projects to elucidate a role for understudied proteins associated with rare diseases. Awards will support generation of preliminary data and/or tools around eligible understudied protein(s).Funding Opportunity Description Introduction The National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH), is transforming the translational science process so that new treatments and cures for disease can be delivered to patients faster. NCATS strives to develop innovations to reduce, remove or bypass costly and time-consuming bottlenecks in the translational research pipeline in an effort to speed the delivery of new drugs, diagnostics and medical devices to patients. This funding opportunity announcement (FOA) aims to promote innovative research to increase knowledge of understudied proteins associated with rare diseases. The submission of small research grant (R03) applications is encouraged from institutions and organizations proposing projects leading to a better understanding of eligible proteins listed below. Small research (R03) grants provide flexibility for initiating discrete, well-defined projects that realistically can be completed in one year and require only limited levels of funding. This program supports different types of projects including, but not limited to, the following: Pilot or feasibility studies; Small, self-contained research projects; Development of research methodology; and/or Development of assays to support compound screening projects; Development of human cell or animal based models. These awards will support generation of preliminary data and tools around eligible understudied protein(s) with the intent of elucidating the function of these proteins in the context of rare disease and obtaining sufficient preliminary data and/or research resources for subsequent grant applications and/or drug discovery projects. These grants are non-renewable. This Funding Opportunity Announcement does not accept applications proposing clinical trial(s). Background The human genome has revealed a great deal about the human proteome, though significant portions of the genome remain understudied. Only a subset of expressed proteins demonstrates the requisite properties to serve as targets for the development of therapeutics. Many bona fide drug targets likely remain to be studied in the Druggable Proteome (DP), which can be defined as the fraction of proteins which have the ability to bind drug-like molecules. The term "drug-like" refers to the physical, biochemical, and pharmacological attributes of small molecule compounds that are generally recognized to be required for efficacious clinical drugs in humans. While the number of proteins in the DP is upwards of 4,500, the existing clinical pharmacopeia is represented by only a few hundred targets, leaving a huge swath of druggable biology unexploited. The expanded exploration of the relationship between the protein and the rare disease phenotype, or the development of a useful tool or reagent can accelerate research into a previously understudied protein. Many interesting and critical biological processes and potential therapeutic avenues remain unexplored because an initial catalyzing event (e.g., association with a biologic process or phenotype, creation of tools or reagents for the protein, etc.) has not yet occurred. The purpose of this FOA is to spark such catalyzing events through the support of small R03 awards to identify novel drug targets for the treatment of human disease, specifically rare disease Objectives and Scope The goal of this specific solicitation is to provide a needed opportunity for the collection of preliminary data around the role of understudied proteins associated with rare diseases. This FOA will provide funding to support research that will characterize new targets for treatment of human disease among the understudied proteins of the Druggable Proteome. These projects should be carried out in a short period of time with limited resources as defined by the funding mechanism. It has been recognized through workshops and publications that understudied proteins become illuminated when (1) there are tools to study the protein (e.g., tools that modulate protein activity) and/or (2) there is biochemical, cellular, or animal model evidence of disease/physiological relevance. This FOA was developed to address the need for expanded research and validation experiments on eligible understudied protein(s), with the intent of producing preliminary data to address the lack of biochemical, cellular, or animal model data associated with many understudied proteins. It is expected that the award will be used to obtain preliminary data and/or research resources for subsequent grant applications and/or drug discovery projects. The NIH supports research on a broad range of diseases that are defined as rare; that is diseases affecting fewer than 200,000 individuals in the United States (per the Rare Disease Act of 2002). Collectively, there are an estimated 7,000 rare diseases, which affect approximately 25-30 million people in the United States. Most are serious or life-threatening, with a disproportionate number of rare diseases affecting children. At this time, effective treatments are available for fewer than 5%. The IDG Program has linked over 6,000 proteins to rare diseases, with over 80% of these proteins considered extremely understudied. For the purposes of this FOA, eligible proteins are those that have an association with rare disease through data mining of the encyclopedia of rare disease annotations for precision medicine (eRAM) and Orphanet, are considered understudied (those proteins that lack small molecule binders and/or have limited biological characterization) and are within a protein family that is traditionally considered druggable.